通过多变量门德尔随机化评估神经退行性疾病上肌痛严重症的潜在因果影响
Xingwang Huang1, Xiuqi Wang2, Yi Yang3
1Department of Cardiothoracic Surgery, The First Hospital of Nanchang, Nanchang, China.
Medicine
|November 20, 2025
概括
骨髓灰质炎 (MG) 因果上增加了阿尔茨海默病 (AD) 的风险. 这项遗传研究发现MG是AD的独立风险因素,表明自身免疫和神经退行之间的联系.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓灰质炎 (MG) 是一种影响神经肌肉信号的自身免疫性疾病.
- 新出现的证据表明,自身免疫性疾病和神经退行之间存在联系.
- 像阿尔茨海默病 (AD),帕金森病 (PD) 和肌缩侧面硬化症 (ALS) 这样的MG和神经退行性疾病之间的因果关系尚未得到充分证实.
研究的目的:
- 用遗传方法调查MG对患AD,PD和ALS的风险的潜在因果影响.
- 探索MG是否是这些神经退行性疾病的独立风险因素.
主要方法:
- 使用全基因组关联研究 (GWAS) 的摘要级数据进行了门德尔随机化 (MR) 分析.
- 无变MR (UVMR) 评估了MG对AD,PD和ALS风险的影响.
- 使用独立的AD GWAS数据集和元分析进行了复制分析.
- 多变量MR (MVMR) 调整为吸烟作为潜在的混因素.
主要成果:
- 紫外线MR表明MG与AD敏感性增加之间存在显著的因果关系 (OR:1.037,P=0.016).
- 对于PD或ALS,没有发现显著的因果关系.
- 复制研究和元分析始终支持MG作为AD的风险因素.
- MVMR证实MG是AD风险的独立贡献者,即使在调整吸烟后 (OR:1.037,P=0.020).
结论:
- 这项研究提供了强有力的遗传证据,表明MG是AD的因果和独立风险因素.
- 这些发现表明,MG中的自身免疫过程和AD中的神经退行性途径之间存在显著的联系.
- 这些结果为了解阿尔茨海默病背后的机制和开发向治疗开辟了新的途径.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Chemical Synapses
11.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.1K
Chemical Synapses
4.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.2K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K


